Dubious Doomsday Scenarios for Health Care Spending Debunked 0

Fair pricing activists applauded the news earlier this month that the FDA approved another drug to cure hepatitis C. That this new medicine is cheaper and treats people quicker than the existing hepatitis C drugs goes to show how fast healthy competition can change the outlook on health spending. Not long ago, health economists were promoting…